Tibet Aim Pharm Inc (002826) - Total Liabilities

Latest as of March 2026: CN¥265.27 Million CNY ≈ $38.82 Million USD

Based on the latest financial reports, Tibet Aim Pharm Inc (002826) has total liabilities worth CN¥265.27 Million CNY (≈ $38.82 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 002826 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Tibet Aim Pharm Inc - Total Liabilities Trend (2013–2025)

This chart illustrates how Tibet Aim Pharm Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Tibet Aim Pharm Inc.

Tibet Aim Pharm Inc Competitors by Total Liabilities

The table below lists competitors of Tibet Aim Pharm Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Kforce Inc. NYSE:KFRC	USA	$241.03 Million
Shenzhen RoadRover Technology Co Ltd SHE:002813	China	CN¥257.39 Million
Shengtak New Material Co Ltd SHE:300881	China	CN¥1.94 Billion
SNT Dynamics Co Ltd KO:003570	Korea	₩295.25 Billion
Beijing Hanyi Innovation Technology Co. Ltd. A SHE:301270	China	CN¥191.34 Million
Topkey Corp TW:4536	Taiwan	NT$4.78 Billion
Clientele JSE:CLI	South Africa	ZAC14.17 Billion
Cantor Equity Partners IV, Inc. Class A Ordinary Shares NASDAQ:CEPF	USA	$265.50K

Liability Composition Analysis (2013–2025)

This chart breaks down Tibet Aim Pharm Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Tibet Aim Pharm Inc (002826) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.78	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tibet Aim Pharm Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tibet Aim Pharm Inc (2013–2025)

The table below shows the annual total liabilities of Tibet Aim Pharm Inc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥201.65 Million ≈ $29.51 Million	+11.48%
2024-12-31	CN¥180.89 Million ≈ $26.47 Million	+1.81%
2023-12-31	CN¥177.68 Million ≈ $26.00 Million	-33.75%
2022-12-31	CN¥268.21 Million ≈ $39.25 Million	+157.00%
2021-12-31	CN¥104.36 Million ≈ $15.27 Million	-52.76%
2020-12-31	CN¥220.94 Million ≈ $32.33 Million	+20.58%
2019-12-31	CN¥183.24 Million ≈ $26.81 Million	+31.32%
2018-12-31	CN¥139.53 Million ≈ $20.42 Million	+8.36%
2017-12-31	CN¥128.76 Million ≈ $18.84 Million	+41.61%
2016-12-31	CN¥90.93 Million ≈ $13.31 Million	-39.16%
2015-12-31	CN¥149.44 Million ≈ $21.87 Million	+67.36%
2014-12-31	CN¥89.30 Million ≈ $13.07 Million	+9.66%
2013-12-31	CN¥81.43 Million ≈ $11.92 Million	--

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$475.17 Million

CN¥3.25 Billion CNY

Market Cap Rank

#12630 Global

#3708 in China

Share Price

CN¥17.03

Change (1 day)

+0.12%

52-Week Range

CN¥15.01 - CN¥22.24

All Time High

CN¥32.76